Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
COGT
COGT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
COGT News
RTW Investments Increases Stake in Cogent Biosciences Significantly
Mar 22 2026
Fool
RTW Investments Increases Stake in Cogent Biosciences
Mar 22 2026
NASDAQ.COM
RTW Investments Increases Stake in Cogent Biosciences by $116 Million
Mar 22 2026
Yahoo Finance
Kynam Capital Reduces Stake in Cogent Biosciences by $48.38 Million
Mar 21 2026
Fool
Kynam Capital Reduces Stake in Cogent Biosciences
Mar 21 2026
NASDAQ.COM
Kynam Capital Management Cuts Viridian Stake by Over $81 Million
Mar 21 2026
Yahoo Finance
Kynam Capital Reduces Stake in Cogent Biosciences by $48 Million
Mar 21 2026
Yahoo Finance
Boone Capital Management Fully Liquidates Cogent Biosciences Stake
Mar 20 2026
Fool
Boone Capital Management Fully Liquidates Cogent Biosciences Stake
Mar 20 2026
NASDAQ.COM
Cogent Biosciences' NDA for Bezuclastinib Accepted by FDA
Mar 17 2026
Newsfilter
Cogent Biosciences' New Drug Application Accepted by FDA
Mar 16 2026
NASDAQ.COM
Sphera Increases Stake in Cogent Biosciences
Mar 13 2026
Fool
Sphera Funds Increases Stake in Cogent Biosciences
Mar 13 2026
NASDAQ.COM
Bezuclastinib Shows Significant Clinical Trial Results
Feb 28 2026
Newsfilter
COGENT SECURITY SECURES FUNDING LED BY BAIN CAPITAL VENTURES, WITH CONTRIBUTIONS FROM GREYLOCK PARTNERS AND DEFINITION
Feb 18 2026
moomoo
Rock Springs Capital Reduces Stake in Cogent Biosciences
Feb 17 2026
Fool
Show More News
